December 7, 2024
SAN DIEGO — Compared with clinical trials, a real-world retrospective analysis has linked the bispecific antibodies epcoritamab (Epkinly) and glofitamab (Columvi) to somewhat poorer outcomes in […]
December 6, 2024
Vaccines for treating and preventing cancer have long been considered a holy grail in oncology. But aside from a few notable exceptions — including the human […]
December 6, 2024
TOPLINE: For patients with early-stage ERBB2 (formerly HER2)–positive breast cancer, injections of increasing doses of autologous conventional type 1 dendritic cells (cDC1) combined with ERBB2-targeted antibodies […]
December 6, 2024
People with cancer, whether they’re undergoing treatment or are in palliative care, like using telehealth to interact with their oncologist. That’s what a number of studies […]
December 5, 2024
TOPLINE: About 1 in 6 young adults with breast cancer experienced a moderate to severe degree of financial difficulty that persisted into early survivorship, with Hispanic […]
December 4, 2024
The US Food and Drug Administration (FDA) has granted accelerated approval to zenocutuzumab-zbco (Bizengri, Merus) as an intravenous infusion for the treatment of certain adults with […]
December 4, 2024
What is the best upfront chemotherapy option for patients with colorectal cancer (CRC) and unresectable liver metastases? A new report demonstrated why patients benefit most from […]
December 4, 2024
TOPLINE: Among patients with cancer, Medicare Advantage and Medicare Part D prescription drug plans frequently used prior authorization for ondansetron and often imposed quantity limits on […]
December 2, 2024
(Reuters) – Novocure said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy, achieving […]